Regulatory effect of Qingchang Wenzhong Decoction on mucosal barrier function in patients with ulcerative colitis
-
摘要: 目的 探讨清肠温中方对溃疡性结肠炎患者肠黏膜屏障及信号转导的影响。方法 回顾性分析56例轻中度溃疡性结肠炎患者的资料,病例来源于北京中医药大学东方医院消化内科门诊及病房,全部给予清肠温中方配方颗粒治疗8周。记录治疗前后改良Mayo评分,同时取病变肠段肠黏膜和正常肠段肠黏膜进行苏木精-伊红染色评价病理组织学改变,PAS染色评估结肠杯状细胞数量,免疫组织化学染色检测转录激活蛋白6(STAT6)及黏蛋白2(MUC2)的表达。结果 清肠温中方治疗能显著降低轻中度溃疡性结肠炎患者的改良Mayo评分,改善其肠黏膜的病理损伤和炎症细胞浸润(P<0.01),增加结肠杯状细胞数量(P<0.01),提高结肠黏膜组织黏蛋白MUC2的表达(P<0.01),抑制STAT6的表达(P<0.01)。结论 清肠温中方治疗轻中度活动期UC患者临床疗效确切,其作用机制与增强肠道屏障功能有关。Abstract: Objective To investigate the effect of Qingchang Wenzhong Decoction(QCWZD) on intestinal mucosal barrier and signal transducer in patients with ulcerative colitis(UC).Methods A retrospective study was conducted to analyze 56 patients with mild to moderate UC who were hospitalized in Department of Gastroenterology, Dongfang Hospital, Beijing University of Traditional Chinese Medicine. All of them were treated with QCWZD granules for 8 weeks. The modified Mayo score before and after treatment was recorded, and normal mucosa and inflammatory mucosa were separated for HE staining and periodic acid Schiff staining. Immunohistochemical staining was used to detect the expression of mucin 2(MUC2) and STAT6.Results QCWZD treatment could significantly reduce the modified Mayo score, improve the pathological damage and inflammatory cell infiltration of intestinal mucosa in patients with mild to moderate UC(P < 0.01), increase the number of colonic goblet cells(P < 0.01), increase the expression of MUC2 in colonic epithelial tissue(P < 0.01), and inhibit the expression of STAT6(P < 0.01).Conclusion QCWZD has a definite clinical effect on patients with mild to moderate active UC, and its mechanism is related to the enhancement of intestinal barrier function.
-
[1] Kotze PG, Heuthorst L, Lightner AL, et al. New insights on the surgical management of ulcerative colitis in the 21st century[J]. Lancet Gastroenterol Hepatol, 2022, 7(7): 679-688. doi: 10.1016/S2468-1253(22)00001-2
[2] Ungaro R, Mehandru S, Allen PB, et al. Ulcerative colitis[J]. Lancet, 2017, 389(10080): 1756-1770. doi: 10.1016/S0140-6736(16)32126-2
[3] Martini E, Krug SM, Siegmund B, et al. Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease[J]. Cell Mol Gastroenterol Hepatol, 2017, 4(1): 33-46. doi: 10.1016/j.jcmgh.2017.03.007
[4] 陈晓伟, 高康丽, 李世荣, 等. 清肠温中方治疗轻中度溃疡性结肠炎56例[J]. 环球中医药, 2018, 11(11): 1826-1829. doi: 10.3969/j.issn.1674-1749.2018.11.056
[5] 王志斌, 陈晨, 郭一, 等. 清肠温中方治疗轻中度溃疡性结肠炎的临床研究[J]. 中国中西医结合杂志, 2018, 38(1): 15-19. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201801004.htm
[6] 吴开春, 梁洁, 冉志华, 等. 炎症性肠病诊断与治疗的共识意见(2018年·北京)[J]. 中国实用内科杂志, 2018, 38(9): 796-813. doi: 10.19538/j.nk2018090106
[7] 张声生, 沈洪, 郑凯, 等. 溃疡性结肠炎中医诊疗专家共识意见(2017)[J]. 中华中医药杂志, 2017, 32(8): 3585-3589. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201708071.htm
[8] Chudy-Onwugaje KO, Christian KE, Farraye FA, et al. A State of the Art Review of New and Emerging Therapies for the Treatment of IBD[J]. Inflamm Bowel Dis, 2019, 25(5): 820-830. doi: 10.1093/ibd/izy327
[9] van der Post S, Jabbar KS, Birchenough G, et al. Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis[J]. Gut, 2019, 68(12): 2142-2151. doi: 10.1136/gutjnl-2018-317571
[10] Hansson GC. Mucus and mucins in diseases of the intestinal and respiratory tracts[J]. J Intern Med, 2019, 285(5): 479-490. doi: 10.1111/joim.12910
[11] Nystrom EEL, Martinez-Abad B, Arike L, et al. An intercrypt subpopulation of goblet cells is essential for colonic mucus barrier function[J]. Science, 2021, 372(6539): eabb1590. doi: 10.1126/science.abb1590
[12] 贺涛, 王伟, 李蕾, 等. 溃疡性结肠炎PCNA、EGFR、MUC2表达水平及临床意义[J]. 医学研究杂志, 2022, 51(3): 104-107. https://www.cnki.com.cn/Article/CJFDTOTAL-YXYZ202203023.htm
[13] 吕冠华, 包永欣, 孙希良, 等. 中药溃结方对难治性溃疡性结肠炎患者肠黏膜EGFR、MUC2表达的影响[J]. 中华中医药学刊, 2017, 35(8): 2128-2130. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS201708056.htm
[14] Yao D, Dai W, Dong M, et al. MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis[J]. EBioMedicine, 2021, 74103751.
[15] 黄则华, 曾悦, 黄春兰. 肠道菌群对黏蛋白2的影响及其作用机制[J]. 胃肠病学, 2019, 24(2): 111-114. https://www.cnki.com.cn/Article/CJFDTOTAL-WIEC201902013.htm
[16] 邹孟龙, 宁芯, 陈雅璐, 等. 四君子汤介导肠道黏膜屏障防治溃疡性结肠炎的研究进展[J]. 中医药导报, 2020, 26(10): 134-137. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZB202010034.htm
[17] Wu Y, Li Y, Ruan Z, et al. Puerarin Rebuilding the Mucus Layer and Regulating Mucin-Utilizing Bacteria to Relieve Ulcerative Colitis[J]. J Agric Food Chem, 2020, 68(41): 11402-11411.
[18] Chiu YH, Lu YC, Ou CC, et al. Lactobacillus plantarum MYL26 induces endotoxin tolerance phenotype in Caco-2 cells[J]. BMC Microbiology, 2013, 13: 190.
[19] Lu P, Burger-van Paassen N, van der Sluis M, et al. Colonic gene expression patterns of mucin Muc2 knockout mice reveal various phases in colitis development[J]. Inflamm Bowel Dis, 2011, 17(10): 2047-2057.
[20] Morampudi V, Dalwadi U, Bhinder G, et al. The goblet cell-derived mediator RELM-beta drives spontaneous colitis in Muc2-deficient mice by promoting commensal microbial dysbiosis[J]. Mucosal Immunol, 2016, 9(5): 1218-1233.
[21] 范恒, 梁丽, 唐庆, 等. 乌梅丸对溃疡性结肠炎大鼠STAT6表达的影响[J]. 中西医结合研究, 2011, 3(3): 127-131. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXYH201103008.htm
[22] 杨立, 肖明明. STAT6蛋白在实验性结肠炎大鼠中的表达及其对细胞因子IFN-γ和IL-4的影响[J]. 胃肠病学和肝病学杂志, 2015, 24(11): 1341-1345. https://www.cnki.com.cn/Article/CJFDTOTAL-WCBX201511018.htm
[23] Linossi EM, Calleja DJ, Nicholson SE. Understanding SOCS protein specificity[J]. Growth Factors, 2018, 36(3-4): 104-117.
[24] Durham GA, Williams JJL, Nasim MT, et al. Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease[J]. Trends Pharmacol Sci, 2019, 40(5): 298-308.
[25] 姜慧, 李军祥, 谭祥, 等. 李军祥教授治疗溃疡性结肠炎经验[J]. 中国中西医结合消化杂志, 2019, 27(3): 232-235. http://zxpw.cbpt.cnki.net/WKD/WebPublication/paperDigest.aspx?paperID=c4bebf95-5842-4efb-b0a5-7ae6d79899cf
[26] 薛明松, 郑玉玉, 张宇峰, 等. 黄连粗多糖协同小檗碱改善溃疡性结肠炎肠黏膜屏障损伤的作用[J]. 中国实验方剂学杂志, 2022, 28(13): 71-76. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202213009.htm
[27] 李思, 沈雁, 钟继红, 等. 黄连提取物小檗碱对溃疡性结肠炎小鼠结肠黏膜机械屏障的影响[J]. 中华全科医学, 2018, 16(9): 1419-1423. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201809004.htm
[28] 张岚琨, 张志强. 氧化苦参碱靶向抑制Th17对肠道黏膜免疫屏障的作用[J]. 沈阳药科大学学报, 2019, 36(12): 1100-1106. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYD201912008.htm
[29] 寇富舜, 程媛, 李亚兰, 等. 青黛对急性溃疡性结肠炎小鼠模型结肠黏膜中性粒细胞迁移浸润的作用影响[J]. 中国中医急症, 2022, 31(1): 58-61. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJZ202201013.htm